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Purpose: To determine whether the human Müller cell line Moorfields/Institute of Ophthalmology-Müller 1 (MIO-M1)
expresses opsins.
Methods: The gene expression of opsins was determined by reverse-transcription PCR (RT–PCR). The presence of opsin
proteins was determined by western blotting and immunocytochemistry. The light sensitivity of the cells was examined
with imaging experiments using the calcium-sensitive dye Fluo-4.
Results:  MIO-M1  cells  express  glial  (glutamine  synthase  [GLUL],  vimentin  [VIM],  glial  fibrillary  acidic  protein
[GFAP], cellular retinaldehyde-binding protein [RLBP1], glial high-affinity glutamate transporter [SLCA1], aquaporin-4
[AQP4], inwardly rectifying potassium channel Kir4.1 [Kir4.1]), neuronal (Thy-1 cell surface antigen [THY1], heavy
neurofilament  polypeptide  [NEFH],  microtubule-associated  protein  2  [MAP2],  neurogenic  differentiation  1
[NEUROD1], neuronal nuclei [NEUN]), and neural progenitor markers (Nestin [NES], paired-type homeobox transcription
factor [PAX6], neurogenic locus notch homolog 1 [NOTCH1]). The cells contain mRNA for the following opsins: blue
opsin (OPN1SW), rhodopsin (OPN2), panopsin (OPN3), melanopsin (OPN4), neuropsin (OPN5), and peropsin (RRH),
as well as for the transducins (guanine nucleotide binding protein [GNAZ], alpha transducing activity polypeptide 1
[GNAT1], alpha transducing activity polypeptide 2 [GNAT2]). The presence of blue opsin and melanopsin was confirmed
with immunocytochemistry and western blotting. The immunoreactivity and mRNA of red-green opsin were found in
some but not all cultures, while the immunoreactivity for rhodopsin was absent in all cultures investigated. Repetitive
stimulation with 480 nm light evoked slow and fast transient calcium responses in the majority of cells investigated, while
irradiation with 600 nm light was ineffective.
Conclusions: The human Müller cell line MIO-M1 expresses opsins. This suggests immortalized Müller cells could be
used as a cellular source to produce human opsins for their potential application as therapeutic agents in patients with
retinitis pigmentosa.
Retinitis  pigmentosa  includes  a  group  of  hereditary
disorders  characterized  by  the  initial  degeneration  of
photoreceptors  [1].  Retinitis  pigmentosa  is  genetically
heterogeneous;  over  130  genes  have  been  identified  that,
when mutated, result in severe vision impairment. Different
therapeutic  strategies  were  developed  in  the  past  to  treat
retinal dystrophies. Viral replacement of mutated genes has
led to the improvement of the phenotypic changes in animal
models of retinitis pigmentosa [2]. Other methods represent
rather  global  strategies  independent  of  the  underlying
mutation.  Such  strategies  include  the  administration  of
vitamins,  calcium  channel  blockers,  and  neuroprotective
growth factors [3-5], as well as the transplantation of cells that
can adopt photoreceptor characteristics such as pluripotent
stem cells and glial cells [6-9].
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Postmortem  patient  eyes  with  almost  complete
photoreceptor loss because of retinitis pigmentosa or age-
related  macular  degeneration  display  preservation  of  a
significant  number  of  inner  retinal  neurons  [1,10-13].  In
animal models of photoreceptor degeneration, the remaining
inner retina that connects to the brain displays remodeling and
degeneration over time [14-18], but can still be functional
[19,20]. Thus, electrical stimulation of the remaining inner
retina by means of visual prostheses [21,22], or the direct
conversion  to  photosensitive  cells  of  the  surviving  inner
retinal  neurons,  are  further  strategies  to  enhance  visual
function in retinal dystrophies. It has been shown that the
ectopic expression of melanopsin or microbial-type rhodopsin
in retinal ganglion cells or bipolar cells of rodless/coneless
mice improves the pupillary reflex and the outcome in various
irradiance detection tasks [19,23,24].
In  addition  to  the  viral  transfer  of  opsin  genes,  it  is
conceivable that the transduction of exogenous opsin proteins
to inner retinal cells might be helpful in enhancing visual
function in retinal dystrophies. The use of human instead of
bacterial  opsins  might  decrease  the  potential  risk  of
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2738inflammatory and immune responses. However, the in vitro
and in vivo transduction properties of human opsins have not
been demonstrated until very recently. A precondition for the
determination of the transduction properties is the production
of sufficient amounts of opsins. Approaches to producing
human  melanopsin  by  using  transformed  bacteria  or
transfected COS-7 cells (a kidney fibroblast cell line of the
vervet monkey) in our laboratory or by a commercial provider
were not successful (data not shown). Thus, we looked for a
human cell line that could be used as a possible source of
opsins. We focused our search on the human Müller cell line
MIO-M1, which is highly proliferative in culture [25,26]. It
has been shown that mammalian Müller cells are capable of
expressing  neuronal  and  photoreceptor  proteins  in  animal
models of retinopathies, as well as under culture conditions
[6-8,27], including proteins of retinal ganglion cells such as
Thy-1 [28]. Spontaneously immortalized human Müller cell
lines such as MIO-M1 may exhibit progenitor characteristics
and may express markers of postmitotic retinal neurons, as
well as S-opsin [26]. Here, we show that cultured MIO-M1
cells express various opsins.
METHODS
Materials: Fluo-4/AM, Pluronic F-127, and Hoechst 33258
were obtained from Molecular Probes (Leiden, Netherlands).
All  other  reagents  were  obtained  from  Sigma-Aldrich
(Taufkirchen,  Germany),  unless  otherwise  indicated.  The
following antibodies were used: rabbit anti-blue opsin (1:200;
Millipore,  Schwalbach,  Germany),  rabbit  anti-red-green
opsin  (1:200;  Millipore),  monoclonal  rat  anti-rhodopsin
(clone 5G6; 1:200; kindly provided by Stefanie M. Hauck,
Dept.  of  Protein  Sciences,  Helmholtz  Center,  Munich,
Germany),  rabbit  anti-melanopsin  (1:200;  Santa  Cruz
Biotechnology,  Santa  Cruz,  CA),  mouse  anti-glutamine
synthetase (1:500; clone GS-6; Millipore), mouse anti-glial
fibrillary acidic protein (GFAP; 1:200; clone Ga5; Sigma-
Aldrich, Taufkirchen, Germany), Cy2-coupled goat antirabbit
IgG  (1:400;  Jackson  ImmunoResearch,  Newmarket,  UK),
Cy2-coupled  goat  antirat  IgG  (1:400;  Jackson
ImmunoResearch  Laboratories),  and  Cy3-coupled  goat
antimouse  IgG  (1:400;  Jackson  ImmunoResearch).  For
western blotting, rabbit antimelanopsin (1:300; Santa Cruz
Biotechnology),  rabbit  anti-OPN1SW  (1:700;  Santa  Cruz
Biotechnology), and antirabbit IgG conjugated with alkaline
phosphatase (1:3000; Chemicon) were used. The pBSII SK+
OPN4  CDS  plasmid  was  kindly  provided  by  Emma  E.
Tarttelin (Department of Visual Neuroscience, Division of
Neuroscience and Psychological Medicine, Imperial College,
London).
Cell  culture:  The  experiments  were  performed  using  the
human Müller cell line MIO-M1 [25] and cultured HEK-293
and human retinal pigment epithelial cells. The cells were
cultured  in  tissue  culture  flasks  (Greiner,  Nürtingen,
Germany)  using  Dulbecco’s  Modified  Eagle’s  medium
(Invitrogen, Paisley, UK) containing 10% fetal bovine serum,
glutamax II, and penicillin/streptomycin in 5% CO2 at 37 °C.
To  carry  out  the  calcium  imaging  experiments  and
immunostaining, the cells were seeded at 1×104 cells per well
in 12-well flat-bottom microtiter plates (Greiner), and allowed
to attach for 48 h using medium supplemented with 10%
serum. PCR was also performed using RNA extracted from
human postmortem retinas. The use of human material was
approved  by  the  Ethics  Committee  of  the  University  of
Leipzig, and was performed according to the declaration of
Helsinki.
Total RNA preparation: Total RNA was isolated from MIO-
M1  cells  with  the  RNeasy  Mini  Kit  (Qiagen,  Hilden,
Germany) using 600 µl of RLT buffer for cell lysis, and from
neural retinal tissues of human donors (postmortem time up
to 24 h) using TRIZOL (Gibco BRL, Paisley, UK). After the
addition of the retinal tissues to TRIZOL (1 ml), the tissues
were  homogenized  using  Ultraturrax  (IKA,  Staufen,
Germany). Retinal RNA was additionally purified using the
RNeasy  Mini  Kit  (Qiagen).  The  quality  of  the  RNA  was
analyzed by agarose gel electrophoresis. The A260/A280 ratio
of optical density was measured using the NanoDrop 1000
device (Peqlab, Erlangen, Germany), and was between 2.0
and 2.2 for all RNA samples, indicating sufficient quality.
Reverse transcription-PCR: After treatment with DNase I
(Roche, Mannheim, Germany), cDNA was synthesized from
1 µg of total RNA using the RevertAid H Minus First Strand
cDNA Synthesis kit (Fermentas, St. Leon-Roth, Germany).
After dilution of the cDNA (1:2) with RNase-free water, PCR
was performed using the Taq PCR Master Mix (Qiagen) and
the primer pairs described in Table 1. One µl (25 ng template
cDNA) of the first-strand mixture and 0.25 µM of each gene-
specific  sense  and  anti-sense  primer  were  used  for
amplification in a final volume of 20 µl. Amplification was
performed for 40 cycles with the PTC-200 Thermal Cycler
(MJ Research, Watertown, MA). Each cycle consisted of 30
s at 94 °C, 45 s at 58 °C, and 90 s at 72 °C. Negative controls
were done by using double-distilled water and samples of
reverse transcription performed with total RNA but omitting
the reverse transcriptase. In all these controls, no amplicons
were detectable (not shown), confirming the specificity of the
PCR results. cDNA samples prepared from the RNA of human
retinas were used as positive controls. The PCR products were
analyzed by agarose (1.7%) gel electrophoresis.
Real-time PCR: The cDNA was diluted (1:2) by the addition
of 20 µl RNase-free water. Semiquantitative real-time PCR
was  performed  with  the  Single-Color  Real-Time  PCR
Detection  System  (BioRad,  Munich,  Germany)  using  the
primer pairs described in Table 1. The PCR amplification
mixture contained 25 ng template cDNA, a specific primer set
(0.25 µM each), and 10 µl of iQ SYBR Green Supermix
(BioRad) in a final volume of 20 µl. The following conditions
were used: initial denaturation and enzyme activation (one
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2740cycle at 95 °C for 3 min) and denaturation, amplification, and
quantification (45 cycles at 95 °C for 30 s, 58 °C for 20 s, and
72 °C for 45 s). This was followed by a melt curve analysis
(81 cycles) to determine the product specificity, wherein the
temperature  was  gradually  increased  (0.5  °C/cycle)  from
55 °C to 95 °C. The fluorescence signal was measured during
every cycle. The amplified samples were analyzed by standard
agarose  gel  electrophoresis.  The  mRNA  expression  was
normalized  to  the  expression  level  of  hypoxanthine
phosphoribosyl-transferase1 (HPRT1). Similar results were
obtained using acidic ribosomal phosphoprotein P1 (RPLP1)
or  glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH)
expression  for  normalization  (data  not  shown).  Statistical
significance was evaluated with the Mann–Whitney U test.
For the calculation of the relative expression changes, we used
the fluorescence signal of lower cycles during the log phase
of the product formation. Real-time PCR efficiency (E) was
calculated  according  to  the  equation  E=10[-1/slope].  The
efficiencies were similar in the investigated range between
0.05 ng and 100 ng cDNA for all target genes (panopsin
[OPN3], 2.14; melanopsin [OPN4], 2.21; rhodopsin [OPN2],
2.18;  peropsin  [RRH],  2.20;  blue  opsin  [OPN1SW],  2.00;
HPRT1,  2.09;  RPLP1,  2.04;  GAPDH,  2.00),  with  the
exception of neuropsin (OPN5; 2.62).
Western blotting: The cells were seeded in 1×105 cells in cell
culture flasks (25 cm2) in 3 ml complete medium until ~70%–
90% confluency was reached. Thereafter, the medium was
removed,  and  the  cells  were  washed  twice  with  cold
phosphate-buffered saline (pH 7.4; Invitrogen). Cytosolic and
membrane proteins of MIO-M1 cells were extracted using the
ProteoJET  Membrane  Protein  Extraction  Kit  (Fermentas)
according to the manufacturer’s instructions. The extracted
proteins were concentrated (~1:100) using the Vivaspin 5000-
System (Satorius, Göttingen, Germany). Proteins from retinal
tissues  were  extracted  with  the  mammalian  cell  lysis  kit
(MCL1; Sigma-Aldrich). Equal amounts of protein (20 µg)
were separated by 10% sodium dodecyl sulfate PAGE (SDS–
PAGE).  Immunoblots  were  probed  with  primary  and
secondary  antibodies,  and  immunoreactive  bands  were
visualized using 5-bromo-4-chloro-3-indolyl phosphate/nitro
blue tetrazolium. No specific signals were detected in the
negative controls made by omitting the primary antibody or
using  purified  rabbit  IgG  (Cell  Signaling  Technologies,
Danvers, MA).
Immunocytochemistry:  For  immunolabeling,  the  cultures
were fixed in 4% paraformaldehyde for 10 min. After several
washing steps in buffered saline, the cultures were incubated
in 5% normal goat serum plus 0.3% Triton X-100 (Sigma-
Aldrich)  in  saline  for  1  h  at  room  temperature  and,
subsequently, in a mixture of primary antibodies overnight at
4  °C.  After  washing  in  saline  plus  0.3%  Triton  X-100,
secondary antibodies and Hoechst 33258 were applied for 2
h at room temperature.
Calcium imaging: The experiments were performed at 21–
23  °C.  After  incubation  of  the  cells  in  culture  medium
containing Fluo-4/AM (10 µM) for 30 min, the cells were
either  dark  adapted  for  45  min  or  stored  under  room
illumination.  The  stock  solution  of  the  dye  was  made  in
dimethyl  sulfoxide  (DMSO)  plus  Pluronic  F-127  (2%).
Thereafter, the microtiter plates with the cells were transferred
to  a  recording  chamber  filled  with  extracellular  solution
containing (in mM) 135 NaCl, 3 KCl, 2 CaCl2, 1 MgCl2, 1
Na2HPO4, 10 HEPES, and 11 glucose. During the recordings,
the cells were superfused with extracellular solution (1 ml/
min). Fluo-4 was excited at 480 nm, and the emission was
recorded with a band-pass filter between 505 nm and 550 nm.
A  conventional  fluorescence  microscope  system  (Till
Figure 1. Expression of retinal glial cell marker genes in Moorfields/
Institute  of  Ophthalmology-Müller  1  (MIO-M1)  cells.  The
expression of the following genes was determined with reverse-
transcription PCR: glutamine synthetase (GLUL), vimentin (VIM),
glial fibrillary acidic protein (GFAP), cellular retinaldehyde-binding
protein  (RLBP1),  the  glial  high-affinity  glutamate  transporter
(SLC1A),  aquaporin-4  (AQP4),  and  the  inwardly  rectifying
potassium channel Kir4.1 (Kir4.1), and β-actin (ACTB). The data
from two independent experiments (1, 2) are shown. The negative
control (-) was done by adding double-distilled water instead of
cDNA.
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2741Photonics, Munich, Germany; consisting of Polychrome IV,
SensiCam, and Till Vision Software; microscope: Axioskop;
Zeiss, Jena, Germany) was used. Repetitive light stimuli were
applied for 10 min; 480 nm light stimuli with a duration of
500 ms were applied with a frequency of one per second, while
600 nm light stimuli with a duration of 18 s were applied every
20 s. During the administration of the 600 nm light stimuli,
Fluo-4  was  excited  with  480  nm  light  stimuli  (duration,
500 ms) every 20 s.
RESULTS
Expression of glial, neuronal, and neural progenitor genes:
Immortalized human Müller cell lines were shown to express
neural progenitor genes and genes for marker proteins of
postmitotic  retinal  neurons  [26].  We  determined  whether
Figure 2. Expression of neuronal and stem cell marker genes in
Moorfields/Institute of Ophthalmology-Müller 1 (MIO-M1) cells.
The expression of the following neuronal genes was determined with
reverse  transcription  PCR:  Thy-1  (THY1),  neurofilament  heavy
polypeptide  (NEFH),  neurogenic  differentiation  1  (NEUROD1),
microtubule-associated  protein  2  (MAP2),  and  neuronal  nuclei
(NEUN). The expression of the following neural progenitor genes
was determined: nestin (NES), paired-type homeobox transcription
factor  (PAX6),  and  neurogenic  locus  notch  homolog  protein  1
(NOTCH1). The data from two independent experiments (1, 2) are
shown. The negative control (-) was done by adding double-distilled
water instead of cDNA.
MIO-M1  cells  contained  mRNA  for  proteins  that  were
characteristic for retinal neuronal, glial, and stem cells. We
found that MIO-M1 cells expressed the following marker
genes of retinal glial cells (Figure 1): glutamine synthetase
(GLUL), the glial intermediate filaments vimentin (VIM) and
glial  fibrillary  acidic  protein  (GFAP),  the  cellular
retinaldehyde-binding protein (RLBP1), the glial high-affinity
glutamate transporter (SLC1A), aquaporin-4 (AQP4), and the
inwardly rectifying potassium channel Kir4.1 (Kir4.1).
The expression of the following marker genes of mature
neurons  was  observed  (Figure  2):  the  marker  of  retinal
ganglion  cells,  Thy-1  (THY1),  the  heavy  neurofilament
protein (NEFH), microtubule-associated protein 2 (MAP2),
the member of the NeuroD family of basic helix–loop–helix
transcription  factors,  neurogenic  differentiation  1
(NEUROD1), and hexaribonucleotide binding protein 3 or
neuronal  nuclei  (NEUN),  which  is  a  splicing  regulator
localized to the nuclei of postmitotic neurons [29]. We found
the  expression  of  the  following  marker  genes  of  neural
progenitors  in  MIO-M1  cells  (Figure  2):  the  intermediate
filament  nestin  (NES),  the  regulator  of  gene  transcription
paired box gene 6 (PAX6), and Notch homolog 1 (NOTCH1).
Retinal tissues from postmortem donors contained transcripts
for all the glial, neuronal, and progenitor genes examined (data
not shown).
Expression of opsins: The mRNA expression of opsins in
MIO-M1  cells  was  determined  with  reverse-transcription
PCR. As shown in Figure 3A, we found transcripts for the
following opsins in the total RNA extracted from MIO-M1
cells:  shortwave  (blue)-sensitive  cone  opsin  (OPN1SW),
rhodopsin (OPN2), panopsin (OPN3), melanopsin (OPN4),
neuropsin (OPN5), and peropsin (RRH). Transcripts for the
long-  and  midwave  (red-green)-sensitive  cone  opsin
(OPN1LW+MW)  were  found  in  three  out  of  seven
independent  experiments.  Transcripts  for  the  retinal  G
protein-coupled receptor (RGR) were apparently not present
in the cells (Figure 3A). As the positive control, the presence
of transcripts for all opsins examined was confirmed in the
total RNA extracted from human postmortem retinas (Figure
3B). Transcripts for melanopsin (OPN4) were also found in
the  RNA  transcribed  from  a  plasmid  that  contained  the
OPN4 gene (Figure 3C). Melanopsin (OPN4) was expressed
in MIO-M1 cells that were cultured in the presence or absence
(for 18 h) of serum (10%; Figure 3D). Using real-time PCR,
we compared the relative expression levels of various opsins
in MIO-M1 cells and retinal tissues. The expression levels of
all opsin genes investigated (with the exception of OPN3 and
OPN5) were significantly lower in MIO-M1 cells compared
to retinal tissues (Figure 3E). In particular, the expression of
rhodopsin  (OPN2)  was  very  high  in  retinal  tissues  when
compared to MIO-M1 cells. The CT values for each gene
determined by real-time PCR are shown in Figure 3F.
Expression of transducins and arrestins: In photoreceptors,
transducins  are  key  components  of  the  phototransduction
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2742cascade,  acting  between  opsins  and  cGMP-
phosphodiesterase,  while  arrestins  are  involved  in  the
desensitization of the photoactivated transduction cascade.
We found that MIO-M1 cells contained transcripts for rod-
and cone-type transducins, whereas transcripts for arrestins
were not detected (Figure 4A). The total RNA extracted from
neural  retinal  tissues  of  postmortem  donors  contained
transcripts for transducins and arrestins (Figure 4B).
Detection of opsin proteins: By using immuncytochemical
staining  of  cell  cultures,  we  found  that  MIO-M1  cells
Figure 3. mRNA expression of opsins in Moorfields/Institute of Ophthalmology-Müller 1 (MIO-M1) cells and human retinas. A: The
expression of the following genes was determined with real-time PCR in MIO-M1 cells and (B) in neural retinal tissues from post-mortem
donors. Long- and midwave-sensitive cone opsin (OPN1LW+MW), shortwave-sensitive cone opsin (OPN1SW), rhodopsin (OPN2), panopsin
(OPN3), melanopsin (OPN4), neuropsin (OPN5), retinal G protein-coupled receptor (RGR), and peropsin (RRH). In addition, the detection
of hypoxanthine phosphoribosyl-transferase (HPRT) transcripts is shown. The data from two independent experiments (1, 2) are shown. The
negative control (-) was done by adding double-distilled water instead of cDNA. C: A plasmid (pBSII SK+OPN4) containing the open reading
frame of melanopsin (OPN4; 1) was used as positive control for the PCR experiments. D: MIO-M1 cells that were cultured for 18 h in the
absence (1) and presence (2), respectively, of fetal bovine serum (10%) contained transcripts for OPN4. E: Relative expression level of opsins
in MIO-M1 cells and postmortem neural retinal tissues. The data were determined by real-time-PCR. The bars represent the cycle numbers
required to detect the transcripts (relative to the cycle number for the detection of HPRT mRNA). The data are the means±standard error of
the mean (SEM) of seven independent experiments. *P value (p)<0.001. F: Mean cycle threshold (CT) values (±SEM) for each gene determined
by real-time PCR.
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2743contained blue opsin and melanopsin (Figure 5). Rhodopsin
immunoreactivity  was  not  detected  in  the  cells,  while
immunoreactivity for red-green opsin was found in some but
not all cultures (Figure 5). The presence of melanopsin and
blue opsin proteins was confirmed by western blotting. Both
proteins were found in the cytosolic and membrane fractions
of MIO-M1 cells (Figure 6A,B). As the control, the presence
of both proteins was confirmed in protein extracts of neural
retinal tissues from postmortem donors (Figures 6A,B). In the
case of blue opsin, two major bands (at ~40 kDa and ~42 kDa)
were found in the protein extracts of retinal tissues, while in
the samples of MIO-M1 cells, the 42 kDa band prevailed
(Figure 6B). The presence of several bands could be attributed
to  posttranslational  modifications  such  as  N-linked
glycosylation, as recently described [30].
As the control, we stained cultured HEK-293 and human
retinal pigment epithelial cells with antibodies against red-
green  opsin,  blue  opsin,  and  melanopsin.  There  was  no
specific immunolabeling of HEK-293 (Figure 5D) or retinal
pigment epithelial cells (not shown) against these opsins.
Though all cells investigated contained transcripts for
GFAP  (Figure  1),  some  cultures  did  not  display
immunoreactivity  of  GFAP  (Figure  5A),  whereas  other
cultures showed very low levels of GFAP immunoreactivity
(Figure 5B). However, the cells could be labeled with an
antibody against glutamine synthetase (Figure 5A). This is in
accordance with a previous study that showed the presence of
glutamine synthetase and the absence of GFAP protein in
MIO-M1 cells [25].
Light-evoked  calcium  responses:  We  found  that  cultured
MIO-M1 cells contained melanopsin and blue opsin (Figure
5 and Figure 6). In a first attempt to prove whether cultured
MIO-M1  cells  are  light  sensitive,  we  performed  imaging
experiments using the calcium-sensitive dye Fluo-4. We used
repetitive stimuli of light with wavelengths of 480 nm and 600
nm, respective experiments. It has been shown in expression
studies  that  human  melanopsin  has  an  absorption  peak
between  420  nm  and  430  nm,  while  murine  melanopsin
exhibits maximal absorbance around 480 nm [31,32]; almost
no light absorbance occurs at 600 nm [33]. Thus, light of a
wavelength  of  480  nm  should  predominantly  activate
melanopsin and rhodopsin, whereas light of a wavelength of
600 nm will predominantly activate red opsin. As shown in
Figure 7A,B, repetitive stimulation of the cells with light of a
wavelength of 480 nm evoked cytosolic calcium responses in
nearly all cells investigated. Light-evoked calcium responses
were observed in cells that were dark-adapted for 45 min
before the beginning of the recordings (Figure 7A), and in
cells  that  were  not  dark-adapted  before  light  stimulation
(Figure 7B). With the onset of light stimulation, the majority
Figure  4.  mRNA  expression  of
phototransduction  proteins.  A:  The
expression  was  determined  with
reverse-transcription  PCR  in
Moorfields/Institute of Ophthalmology-
Müller 1 (MIO-M1) cells. B: In human
post-mortem  neural  retinas.  The
expression of the following genes was
determined with RT–PCR: transducin-α
(GNAZ),  rod-type  transducin-α
(GNAT1),  cone-specific  transducin-α
(GNAT2), retinal arrestin (cone arrestin;
ARR3),  and  S  antigen  (rod
photoreceptor arrestin; SAG). The data
from two independent experiments (1,
2) are shown. The negative control (-)
was  done  by  adding  double-distilled
water instead of cDNA.
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2744Figure 5. Immunolabeling of opsins in Moorfields/Institute of Ophthalmology-Müller 1 (MIO-M1) cells. A: Labeling of blue opsin and
melanopsin, respectively, in MIO-M1 cells. The cells were counterstained against glutamine synthetase (GS) and GFAP, respectively. Double
labeling yielded a yellow-orange merge signal. B: Labeling of rhodopsin and red-green opsin, respectively, in MIO-M1 cells. The cells were
counterstained against GFAP. C: Control culture of MIO-M1 cells that was stained with secondary antibodies (goat antirabbit IgG and goat
antimouse IgG) and without primary antibodies. No nonspecific labeling was observed either, following incubation with goat antirat IgG (not
shown). D: Immunostaining of HEK-293 cells against melanopsin, blue opsin, and red green opsin, respectively. The cells were counterstained
against glutamine synthetase (GS). Cell nuclei were labeled with the DNA dye Hoechst 33258 (blue). Bars are 20 µm.
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2745of the responding cells displayed a slowly developing rise in
calcium, which reached the maximum after 3–4 min. In most
cells, the cytosolic calcium level remained elevated during the
recording period of 10 min. In addition to the slow rise in
calcium, many of the responding cells also displayed fast
transient calcium rises, which occurred with a latency of 2–3
min  after  the  onset  of  light  stimulation  (Figure  7A,B).
Irradiation of MIO-M1 cells with 600 nm light did not evoke
calcium responses in the majority of cells investigated (19 out
of 21; Figure 7C). In contrast, irradiation with 480 nm light
evoked calcium responses in most of the cells investigated (46
out of 47 cells).
DISCUSSION
Spontaneously immortalized human Müller cell lines such as
MIO-M1 were shown to express neural progenitor genes such
as  PAX6  and  NOTCH1,  as  well  as  various  genes
characteristically for postmitotic retinal neurons [26]. In the
presence of extracellular matrix, growth factors, or retinoic
acid,  these  cells  can  acquire  neural  morphology  [26].
Subretinal or vitreal transplantation of these cells results in
translocation of the cells into the retinal parenchyma and the
expression  of  neuronal  markers  [26].  The  present  results
confirm the previous finding [26] that MIO-M1 cells express
marker  genes  of  neural  progenitor,  glial,  and  postmitotic
neuronal cells (Figure 1 and Figure 2). In addition, we have
shown that MIO-M1 cells express various opsins (Figure 3A),
contain blue opsin and melanopsin proteins (Figure 5 and
Figure 6), and display cytosolic calcium rises in response to
repetitive light stimulation (Figure 7). Cytosolic calcium rises
were induced in response to 480 nm light (Figure 7A,B) but
not to 600 nm light (Figure 7C). These calcium responses
might be induced by activation of blue opsin and melanopsin.
The absence of calcium responses to 600 nm light irradiation
is in agreement with the fact that we did not find transcripts
for the red-green-sensitive cone opsin in the majority of RT–
PCR experiments done. However, whether the light-evoked
calcium  responses  were  mediated  by  activation  of  the
phototransduction cascade remains to be established in future
investigations.  The  expression  of  transducins  (Figure  4A)
does not exclude this possibility.
The  kinetics  of  the  slow  and  fast  cytosolic  calcium
responses in MIO-M1 cells is similar to the kinetics of light-
evoked  calcium  responses  in  Müller  cells,  which  were
recorded in whole-mount and slice preparations of the guinea
pig retina [34]. In Müller cells of the guinea pig, the slow light-
induced  calcium  responses  are  mediated  by  cellular
hyperpolarization, which causes a calcium influx from the
extracellular space, whereas the fast light-induced calcium
Figure 6. Detection of melanopsin and
blue  opsin  in  Moorfields/Institute  of
Ophthalmology-Müller  1  (MIO-M1)
cells and human retinas by western blot
analysis. A: Melanopsin (Me; 65 kDa)
was  found  in  the  cytosolic  (Cyt)  and
membrane (Mem) fractions of MIO-M1
cells.  As  the  control,  the  presence  of
melanopsin  was  detected  in  neural
retinal  tissues  from  two  postmortem
donors (1, 2). The blots were stained
with  (a)  and  without  (b)  the  first
antibody.  B:  Presence  of  blue  opsin
(BO; 40 and 42 kDa) in the cytosolic
(Cyt) and membrane (Mem) fractions of
MIO-M1 cells and in two neural retinas
(R1, R2), respectively (a). The isotype
control  (b)  was  made  with  purified
rabbit IgG.
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2746responses  are  mediated  by  the  release  of  calcium  from
intracellular  stores,  in  part  after  activation  of  purinergic
receptors [34]. Autocrine activation of purinergic receptors
after the release of ATP from retinal glial cells has been
described as underlying the glial calcium waves in retinal
tissue preparations [35] that have a kinetics similar to the fast
calcium responses observed in MIO-M1 cells. It could be, but
remains to be proven, that the light-induced ion flux that
underlies the slow calcium response causes a swelling of
MIO-M1 cells, which induces a release of ATP from the cells
[36],  resulting  in  the  autocrine  activation  of  purinergic
receptors  and  induction  of  the  fast  transient  calcium
responses. Further investigations are required to determine the
mechanisms of the light-induced calcium responses in MIO-
M1 cells.
In addition to rhodopsin, blue opsin, and melanopsin, we
found the expression of panopsin, neuropsin, and peropsin in
the neural retina (Figure 3B) and MIO-M1 cells (Figure 3A).
The functional roles of these opsins in MIO-M1 cells are
unclear. However, because Müller cells were usually found to
express various neuronal and photoreceptor proteins under
culture conditions [7,27,28], it cannot be ruled out that the
expression of opsins is a component of the reactivation of
neural progenitor characteristics in gliotic Müller cells, which
is  probably  a  precondition  of  neuronal  regeneration  by
transdifferentiation from Müller cells [6-8,37]. Very little is
known regarding the functional roles of panopsin, neuropsin,
and peropsin in the retina [38]. Peropsin was described as
being expressed in the retinal pigment epithelium [39], and it
was suggested that it functions as a retinal isomerase [40]. A
similar function of Müller cells, which are implicated in the
regeneration  of  cone  photopigments  [41],  remains  to  be
determined. Panopsin was described as being expressed in
different tissues, including the brain, liver, and retina [42].
Neuropsin was found to be localized to chicken amacrine and
ganglion cell layer neurons, and it was suggested that it has a
functional role in the reception of UV light [43]. It has also
been suggested that neuropsin mediates the phototransduction
in cells of the paraventricular organ of birds, which regulates
seasonal  reproduction  [44].  However,  different  opsins  are
much more widely distributed in the body, and they mediate,
for example, the light sensitivity of the skin [45].
Although MIO-M1 cells contain GFAP mRNA (Figure
1), the cells either do not contain GFAP protein or do so at a
very low level (Figure 5). The absence of GFAP protein in
MIO-M1 cells is in accordance with a previous study [25].
Upregulation of GFAP is a common marker of Müller cell
gliosis in situ [46]. However, it has been shown in the chicken
retina that Müller cells that increase the expression of GFAP
in response to retinal damage do not reenter the cell cycle,
while Müller cells that fail to increase the expression of GFAP
proliferate and might represent a source of neural regeneration
[47].  It  is  conceivable  but  remains  to  be  proven  that  the
absence or low expression of GFAP protein in MIO-M1 cells
is a precondition of the high proliferative activity of the cells.
It  remains  to  be  proven  whether  transduction  of
exogenous opsin proteins into the retina in vivo, that is, after
intravitreal administration, might represent an approach to
Figure 7. Light-evoked calcium responses in cultured Moorfields/
Institute of Ophthalmology-Müller 1 (MIO-M1) cells. A: Responses
of cells with dark adaptation are shown. B, C: Responses of cells
without  previous  dark  adaptation  are  shown.  The  cells  were
repetitively illuminated with light of 480 nm (A, B) and 600 nm
(C), respectively. The traces represent the light emission alterations
of the calcium-sensitive dye, Fluo-4, recorded between 505 nm and
550 nm; an increase in the fluorescence ratio reflects an elevation in
cytosolic free calcium. The relative fluorescence change over time
was calculated relative to the fluorescence measured at the beginning
of the light stimulation (ΔF/F0) and is given in percentages. Each
trace represents the calcium response of one cell. Arrows indicate
fast transient responses.
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2747improving  visual  function  in  retinal  dystrophies.  It  is
conceivable that patients may periodically receive intravitreal
injections of opsins. Periodical intravitreal injections of agents
directed against the vascular endothelial growth factor is a
common procedure for treating exudative age-related macular
degeneration. To enhance the efficiency of cell transduction,
opsins might be coupled to cell-penetrating peptides, that is,
through biotinylization. It has been shown, for example, that
intravitreal  administration  of  TAT  protein-coupled
fluorophores  or  peptides  results  in  preferential  uptake  by
retinal ganglion cells [48,49]. Intravitreal injection of a TAT
protein-coupled antiapoptotic protein was shown to inhibit the
apoptosis induced by optic nerve lesions in mice [50].
The  present  results  suggest  that  immortalized  human
Müller  cells  could  represent  a  potential  source  for  the
production of therapeutic opsins. These cells have a high
proliferation rate in culture, and can be frozen and thawed
several  times  without  losing  their  characteristics  [26].
However, further research is required to reveal the production
conditions, transduction properties, and functional efficiency
of human opsins. In addition to a therapeutic purpose, MIO-
M1 cells may be used to produce sufficient amounts of opsins
for basic research on protein structure and phototransduction
[38].
We found that MIO-M1 cells contain at least two opsins,
blue opsin and melanopsin (Figure 5 and Figure 6). Various
opsins have different advantages and disadvantages in their
potential therapeutic use [19]. Melanopsin exerts influence
preferentially  at  high  irradiances  and  responds  better  to
sustained  stimuli.  Thus,  the  use  of  an  opsin  mixture  is
conceivable.  In  addition,  microbial-type  rhodopsins  are
preferred under conditions in which the phototransduction
cascade is not functional; channel rhodopsin-2 directly forms
light-gated ion channels, and its conformational change is
caused by reversible photo-isomerization of the chromophore
group [51].
ACKNOWLEDGMENTS
The authors thank Franziska Rickers for excellent technical
assistance.  This  work  was  supported  by  grants  from  the
Deutsche  Forschungsgemeinschaft  (GRK  1097/1,  RE
849/10–2, RE 849/12–1 to A.R.; KO 1547/6–1 to L.K.).
REFERENCES
1. Milam AH, Li ZY, Fariss RN. Histopathology of the human
retina  in  retinitis  pigmentosa.  Prog  Retin  Eye  Res  1998;
17:175-205. [PMID: 9695792]
2. Bainbridge JW, Tan MH, Ali RR. Gene therapy progress and
prospects:  the  eye.  Gene  Ther  2006;  13:1191-7.  [PMID:
16838031]
3. Li T, Sandberg MA, Pawlyk BS, Rosner B, Hayes KC, Dryja
TP,  Berson  EL.  Effect  of  vitamin  A  supplementation  on
rhodopsin  mutants  threonine-17  >  methionine  and
proline-347 > serine in transgenic mice and in cell cultures.
Proc  Natl  Acad  Sci  USA  1998;  95:11933-8.  [PMID:
9751768]
4. Barabas  P,  Cutler  Peck  C,  Krizaj  D.  Do  calcium  channel
blockers rescue dying photoreceptors in the Pde6brd1 mouse?
Adv Exp Med Biol 2010; 664:491-9. [PMID: 20238051]
5. Tao W, Wen R, Goddard MB, Sherman SD, O'Rourke PJ,
Stabila PF, Bell WJ, Dean BJ, Kauper KA, Budz VA, Tsiaras
WG, Acland GM, Pearce-Kelling S, Laties AM, Aguirre GD.
Encapsulated  cell-based  delivery  of  CNTF  reduces
photoreceptor  degeneration  in  animal  models  of  retinitis
pigmentosa.  Invest  Ophthalmol  Vis  Sci  2002;  43:3292-8.
[PMID: 12356837]
6. Ooto S, Akagi T, Kageyama R, Akita J, Mandai M, Honda Y,
Takahashi  M.  Potential  for  neural  regeneration  after
neurotoxic injury in the adult mammalian retina. Proc Natl
Acad Sci USA 2004; 101:13654-9. [PMID: 15353594]
7. Takeda  M,  Takamiya  A,  Jiao  JW,  Cho  KS,  Trevino  SG,
Matsuda T, Chen DF. α-Aminoadipate induces progenitor cell
properties of Müller glia in adult mice. Invest Ophthalmol Vis
Sci 2008; 49:1142-50. [PMID: 18326742]
8. Wan J, Zheng H, Chen ZL, Xiao HL, Shen ZJ, Zhou GM.
Preferential regeneration of photoreceptor from Müller glia
after  retinal  degeneration  in  adult  rat.  Vision  Res  2008;
48:223-34. [PMID: 18155124]
9. Wang S, Lu B, Girman S, Duan J, McFarland T, Zhang QS,
Grompe M, Adamus G, Appukuttan B, Lund R. Non-invasive
stem cell therapy in a rat model for retinal degeneration and
vascular  pathology.  PLoS  ONE  2010;  5:e9200.  [PMID:
20169166]
10. Santos A, Humayun MS, de Juan E Jr, Greenburg RJ, Marsh
MJ, Klock IB, Milam AH. Preservation of the inner retina in
retinitis  pigmentosa.  A  morphometric  analysis.  Arch
Ophthalmol 1997; 115:511-5. [PMID: 9109761]
11. Medeiros NE, Curcio CA. Preservation of ganglion cell layer
neurons  in  age-related  macular  degeneration.  Invest
Ophthalmol Vis Sci 2001; 42:795-803. [PMID: 11222543]
12. Papermaster DS, Windle J. Death at an early age. Apoptosis in
inherited retinal degenerations. Invest Ophthalmol Vis Sci
1995; 36:977-83. [PMID: 7730031]
13. Humayun MS, Prince M, de Juan E Jr, Barron Y, Moskowitz
M,  Klock  IB,  Milam  AH.  Morphometric  analysis  of  the
extramacular  retina  from  postmortem  eyes  with  retinitis
pigmentosa.  Invest  Ophthalmol  Vis  Sci  1999;  40:143-8.
[PMID: 9888437]
14. Strettoi  E,  Pignatelli  V,  Rossi  C,  Porciatti  V,  Falsini  B.
Remodeling of second-order neurons in the retina of rd/rd
mutant  mice.  Vision  Res  2003;  43:867-77.  [PMID:
12668056]
15. Marc RE, Jones BW, Anderson JR, Kinard K, Marshak DW,
Wilson JH, Wensel T, Lucas RJ. Neural reprogramming in
retinal  degeneration.  Invest  Ophthalmol  Vis  Sci  2007;
48:3364-71. [PMID: 17591910]
16. Strettoi E, Pignatelli V. Modifications of retinal neurons in a
mouse model of retinitis pigmentosa. Proc Natl Acad Sci USA
2000; 97:11020-5. [PMID: 10995468]
17. Jones BW, Watt CB, Frederick JM, Baehr W, Chen CK, Levine
EM, Milam AH, Lavail MM, Marc RE. Retinal remodeling
triggered by photoreceptor degenerations. J Comp Neurol
2003; 464:1-16. [PMID: 12866125]
18. Semo M, Lupi D, Peirson SN, Butler JN, Foster RG. Light-
induced c-fos in melanopsin retinal ganglion cells of young
Molecular Vision 2011; 17:2738-2750 <http://www.molvis.org/molvis/v17/a296> © 2011 Molecular Vision
2748and aged rodless/coneless (rd/rd cl) mice. Eur J Neurosci
2003; 18:3007-17. [PMID: 14656296]
19. Lin  B,  Koizumi  A,  Tanaka  N,  Panda  S,  Masland  RH.
Restoration of visual function in retinal degeneration mice by
ectopic expression of melanopsin. Proc Natl Acad Sci USA
2008; 105:16009-14. [PMID: 18836071]
20. Zhu Y, Tu DC, Denner D, Shane T, Fitzgerald CM, Van Gelder
RN.  Melanopsin-dependent  persistance  and
photopotentiation of murine pupillary light responses. Invest
Ophthalmol Vis Sci 2007; 48:1268-75. [PMID: 17325172]
21. Zrenner E. Will retinal implants restore vision? Science 2002;
295:1022-5. [PMID: 11834821]
22. Weiland JD, Liu W, Humayun MS. Retinal prosthesis. Annu
Rev Biomed Eng 2005; 7:361-401. [PMID: 16004575]
23. Bi A, Cui J, Ma YP, Olshevskaya E, Pu M, Dizhoor AM, Pan
ZH.  Ectopic  expression  of  a  microbial-type  rhodopsin
restores  visual  responses  in  mice  with  photoreceptor
degeneration. Neuron 2006; 50:23-33. [PMID: 16600853]
24. Lagali PS, Balya D, Awatramani GB, Münch TA, Kim DS,
Busskamp V, Cepko CL, Roska B. Light-activated channels
targeted to ON bipolar cells restore visual function in retinal
degeneration.  Nat  Neurosci  2008;  11:667-75.  [PMID:
18432197]
25. Limb GA, Salt TE, Munro PM, Moss SE, Khaw PT. In vitro
characterization  of  a  spontaneously  immortalized  human
Müller cell line (MIO-M1). Invest Ophthalmol Vis Sci 2002;
43:864-9. [PMID: 11867609]
26. Lawrence JM, Singhal S, Bhatia B, Keegan DJ, Reh TA, Luthert
PJ, Khaw PT, Limb GA. MIO-M1 cells and similar Müller
glial cell lines derived from adult human retina exhibit neural
stem  cell  characteristics.  Stem  Cells  2007;  25:2033-43.
[PMID: 17525239]
27. Kubrusly RC, Panizzutti R, Gardino PF, Stutz B, Reis RA,
Ventura  AL,  de  Mello  MC,  de  Mello  FG.  Expression  of
functional  dopaminergic  phenotype  in  purified  cultured
Müller cells from vertebrate retina. Neurochem Int 2008;
53:63-70. [PMID: 18582514]
28. Dabin I, Barnstable CJ. Rat retinal Müller cells express Thy-1
following neuronal cell death. Glia 1995; 14:23-32. [PMID:
7615343]
29. Kim KK, Adelstein RS, Kawamoto S. Identification of neuronal
nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene
family  of  splicing  factors.  J  Biol  Chem  2009;
284:31052-61. [PMID: 19713214]
30. Sato K, Nakazawa M, Takeuchi K, Mizukoshi S, Ishiguro S. S-
opsin  protein  is  incompletely  modified  during  N-glycan
processing in Rpe65−/− mice. Exp Eye Res 2010; 91:54-62.
[PMID: 20398652]
31. Melyan Z, Tarttelin EE, Bellingham J, Lucas RJ, Hankins MW.
Addition  of  human  melanopsin  renders  mammalian  cells
photoresponsive.  Nature  2005;  433:741-5.  [PMID:
15674244]
32. Qiu X, Kumbalasiri T, Carlson SM, Wong KY, Krishna V,
Provencio I, Berson DM. Induction of photosensitivity by
heterologous  expression  of  melanopsin.  Nature  2005;
433:745-9. [PMID: 15674243]
33. Walker  MT,  Brown  RL,  Cronin  TW,  Robinson  PR.
Photochemistry of retinal chromophore in mouse melanopsin.
Proc  Natl  Acad  Sci  USA  2008;  105:8861-5.  [PMID:
18579788]
34. Rillich K, Gentsch J, Reichenbach A, Bringmann A, Weick M.
Light-stimulation evokes two different calcium responses in
Müller glial cells of the guinea pig retina. Eur J Neurosci
2009; 29:1165-76. [PMID: 19302152]
35. Newman EA. Propagation of intercellular calcium waves in
retinal  astrocytes  and  Müller  cells.  J  Neurosci  2001;
21:2215-23. [PMID: 11264297]
36. Wurm  A,  Pannicke  T,  Iandiev  I,  Francke  M,  Hollborn  M,
Wiedemann P, Reichenbach A, Osborne NN, Bringmann A.
Purinergic signaling involved in Müller cell function in the
mammalian  retina.  Prog  Retin  Eye  Res  2011;  30:324-42.
[PMID: 21689780]
37. Bringmann A, Iandiev I, Pannicke T, Wurm A, Hollborn M,
Wiedemann  P,  Osborne  NN,  Reichenbach  A.  Cellular
signaling  and  factors  involved  in  Müller  cell  gliosis:
neuroprotective and detrimental effects. Prog Retin Eye Res
2009; 28:423-51. [PMID: 19660572]
38. Nickle B, Robinson PR. The opsins of the vertebrate retina:
insights  from  structural,  biochemical,  and  evolutionary
studies.  Cell  Mol  Life  Sci  2007;  64:2917-32.  [PMID:
17726575]
39. Sun  H,  Gilbert  DJ,  Copeland  NG,  Jenkins  NA,  Nathans  J.
Peropsin, a novel visual pigment-like protein located in the
apical microvilli of the retinal pigment epithelium. Proc Natl
Acad Sci USA 1997; 94:9893-8. [PMID: 9275222]
40. Bellingham J, Wells DJ, Foster RG. In silico characterisation
and chromosomal localisation of human RRH (peropsin) -
implications for opsin evolution. BMC Genomics 2003; 4:3.
[PMID: 12542842]
41. Muniz A, Villazana-Espinoza ET, Hatch AL, Trevino SG, Allen
DM,  Tsin  AT.  A  novel  cone  visual  cycle  in  the  cone-
dominated retina. Exp Eye Res 2007; 85:175-84. [PMID:
17618621]
42. Halford  S,  Freedman  MS,  Bellingham  J,  Inglis  SL,
Poopalasundaram  S,  Soni  BG,  Foster  RG,  Hunt  DM.
Characterization of a novel human opsin gene with wide
tissue expression and identification of embedded and flanking
genes  on  chromosome  1q43.  Genomics  2001;  72:203-8.
[PMID: 11401433]
43. Yamashita  T,  Ohuchi  H,  Tomonari  S,  Ikeda  K,  Sakai  K,
Shichida Y. Opn5 is a UV-sensitive bistable pigment that
couples with Gi subtype of G protein. Proc Natl Acad Sci USA
2010; 107:22084-9. [PMID: 21135214]
44. Nakane  Y,  Ikegami  K,  Ono  H,  Yamamoto  N,  Yoshida  S,
Hirunagi K, Ebihara S, Kubo Y, Yoshimura T. A mammalian
neural tissue opsin (Opsin 5) is a deep brain photoreceptor in
birds. Proc Natl Acad Sci USA 2010; 107:15264-8. [PMID:
20679218]
45. Tsutsumi M, Ikeyama K, Denda S, Nakanishi J, Fuziwara S,
Aoki  H,  Denda  M.  Expressions  of  rod  and  cone
photoreceptor-like  proteins  in  human  epidermis.  Exp
Dermatol 2009; 18:567-70. [PMID: 19493002]
46. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann
P, Skatchkov SN, Osborne NN, Reichenbach A. Müller cells
in the healthy and diseased retina. Prog Retin Eye Res 2006;
25:397-424. [PMID: 16839797]
Molecular Vision 2011; 17:2738-2750 <http://www.molvis.org/molvis/v17/a296> © 2011 Molecular Vision
274947. Fischer  AJ,  Reh  TA.  Potential  of  Müller  glia  to  become
neurogenic  retinal  progenitor  cells.  Glia  2003;  43:70-6.
[PMID: 12761869]
48. Dietz GP, Kilic E, Bähr M. Inhibition of neuronal apoptosis in
vitro and in vivo using TAT-mediated protein transduction.
Mol Cell Neurosci 2002; 21:29-37. [PMID: 12359149]
49. Barnett  EM,  Elangovan  B,  Bullok  KE,  Piwnica-Worms  D.
Selective cell uptake of modified Tat peptide-fluorophore
conjugates in rat retina in ex vivo and in vivo models. Invest
Ophthalmol Vis Sci 2006; 47:2589-95. [PMID: 16723475]
50. Dietz GPH, Kilic E, Bähr M. Inhibition of neuronal apoptosis
in vitro and in vivo using TAT-mediated protein transduction.
Mol Cell Neurosci 2002; 21:29-37. [PMID: 12359149]
51. Nagel G, Szellas T, Huhn W, Kateriya S, Adeishvili N, Berthold
P, Ollig D, Hegemann P, Bamberg E. Channelrhodopsin-2, a
directly light-gated cation-selective membrane channel. Proc
Natl Acad Sci USA 2003; 100:13940-5. [PMID: 14615590]
Molecular Vision 2011; 17:2738-2750 <http://www.molvis.org/molvis/v17/a296> © 2011 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 17 October 2011. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
2750